Search by Drug Name or NDC
NDC 00406-9959-03 TEMAZEPAM 22.5 mg/1 Details
TEMAZEPAM 22.5 mg/1
TEMAZEPAM is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by SpecGx LLC. The primary component is TEMAZEPAM.
MedlinePlus Drug Summary
Temazepam is used on a short-term basis to treat insomnia (difficulty falling asleep or staying asleep). Temazepam is in a class of medications called benzodiazepines. It works by slowing activity in the brain to allow sleep.
Related Packages: 00406-9959-03Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Temazepam
Product Information
| NDC | 00406-9959 |
|---|---|
| Product ID | 0406-9959_c3efd031-500e-4d4c-a75e-87d2197d2858 |
| Associated GPIs | 60201030000108 |
| GCN Sequence Number | 058570 |
| GCN Sequence Number Description | temazepam CAPSULE 22.5 MG ORAL |
| HIC3 | H21 |
| HIC3 Description | SEDATIVE-HYPNOTICS - BENZODIAZEPINES |
| GCN | 24036 |
| HICL Sequence Number | 001592 |
| HICL Sequence Number Description | TEMAZEPAM |
| Brand/Generic | Generic |
| Proprietary Name | TEMAZEPAM |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | temazepam |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | CAPSULE |
| Route | ORAL |
| Active Ingredient Strength | 22.5 |
| Active Ingredient Units | mg/1 |
| Substance Name | TEMAZEPAM |
| Labeler Name | SpecGx LLC |
| Pharmaceutical Class | Benzodiazepine [EPC], Benzodiazepines [CS] |
| DEA Schedule | CIV |
| Marketing Category | NDA |
| Application Number | NDA018163 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00406-9959-03 (00406995903)
| NDC Package Code | 0406-9959-03 |
|---|---|
| Billing NDC | 00406995903 |
| Package | 30 CAPSULE in 1 BOTTLE (0406-9959-03) |
| Marketing Start Date | 2010-02-23 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 2.41876 |
| Pricing Unit | EA |
| Effective Date | 2024-02-21 |
| NDC Description | TEMAZEPAM 22.5 MG CAPSULE |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1, 6 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis